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This model was designed to mimic the situation where a patient has de-
veloped VF and is unsupported for a period of time before basic life sup-
port is started and then a short time later, advanced life support is started.
These results suggest that a biphasic waveform has increased efficacy over
a monophasic waveform in situations approximated by this model.
diac output. After 2 min of cross circulation, defibrillation was attempted. M
and Bi OFTs were determined in the same fashion as above. The first shock
strength for the long VF OFT determination for each waveform was the OFT
determined at the beginning of the study. Once defibrillated, the animal was
resuscitated aggressively and allowed to recover for 45 min before the next
VF episode.
Shown are the mean ± s.d. in energyforthe two waveforms and situations
tested. M OFT was 40% higher for long VF as compared to short VF (p <
0.051. Bi OFT was 10% higher for long VF as compared to short VF (p = NSI.
For long and short VF combined, Bi OFT was 67% lower than M OFT (p <
0051
mean ± SO, *p < 0.05. V5 SU, # P < 0.05 V5 G2, G3
H in G2 and G3 was decreased by HUT, whereas HUT did not decrease
H in Gl. H, land T in Gl during HUT were significantly higher than those
in G2 and G3, respectively. Findings were consistent with exaggerated sym-
pathetic and failed withdrawal of parasympathetic activity during HUT in pa-
tients with T-lTAS.
Conclusions: Unusual autonomic responses to orthostatic stress can
cause prolonged asystole, and this autonomic nerve dysfunction may lead
to sudden cardiac death associated with cardiovascular collapse.
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Therapeutic Implications of the Use of
Transesophageal Echocardiography in I.C.U.
Patients with Unexplained Hypoxemia
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A life-threatening cardiac asystole can be a malignant manifestation of vaso-
vagal syncope induced by head-up tilt (HUT) testing. To investigate the mech-
anism of HUT-induced life-threatening cardiac asystole (T-lTAS), we mea-
sured a temporal change of frequency domain heart rate variability indices
(HRV) in 25 patients (pts) with syncope of undetermined etiology. Three pts
137 ± 13 years, 2 male) had T-LTAS episode; asystole :0:10 seconds and car-
diopulmonary resuscitation was necessary (Group 1, G1). Ten pts (48 ± 31
years, 6 male) had positive test (syncope was induced by HUT) but no asys-
tole (Group 2, G2). and 12 pts (55 ± 20 years, 5 male! in negative test (Group
3, G3). After 10 min in supine (Su), HUT (80') was performed up to 40 min.
Power spectra of low (l, 0.04 Hzl, high (H, 0.15-0.40 Hz) and total (T, 0.01-
1.00 Hz) frequency were measured in consecutive 2 min segments through-
out the study. Maximally changed values (Mx) in HR, systolic blood pressure
(BPs) and HRV during HUT were compared among 3 groups. Results; Mx
were obtained at 2 min or 4 min before the moment of T-lTAS or syncope in
Gland G2, respectively.
The aim of this prospective study was to evaluate the diagnostic and ther-
apeutic implications of transesophageal echocardiography (TEEI in critically
ill patients with unexplained hypoxemia hospitalized in a generallCU.
Patients and method; Between January 1st, 1992 and May 31 st. 1993,
transthoracic (TIE) and TEE were performed in 31 patients (mean age: 61 ±
14, Apache II Score: 20 ± 7, mechanical ventilation: 74 p.cent! with severe
(Pa02/Fi02 < 200) and unexplained hypoxemia. The results of each TEE ex-
amination were compared with the clinical and TIE data. The following clas-
sification was used: class 00 = the TEE results disabled TIE diagnosis; class
o = the TEE results were similar to TIE results; class 1 ~ the TEE results
revealed a new but minor finding; class 2 = the TEE results revealed a new
and major finding without therapeutic consequences; class 3 = the TEE re-
sulted in immediate therapeutic modifications. All TEE data were reviewed
by 2 different intensive care staff members. In case of disagreement the re-
sults were discussed until a consensus was reached. Results are; class 0 ~
16 patients (52 p.cent). class 00 = 1 patient (3 p.cent!, class 1: 4 patients
(13 p.cent), class 2 = 4 patients (13 p.cent), class 3 ~ 6 patients 119 p.cent).
In these last 10 patients (32 p.cent), TEE findings were judged significant:
three atrial septal defect and one patent foramen ovale (two of them were
ventilated with PEEP and were rapidly weaned, and one was breathing spon-
taneously!; two mitral regurgitations requiring surgery, one important mitral
vegetation (requiring administration of antimicrobial therapy) and three left
atrial thrombus (requiring new antithrombotic therapy in one case). In conclu-
sion: Our results suggest that TEE is an important advance in the therapeutic
management of hypoxemia in critically ill patients.
Patients with WPW Syndrome and Paroxysmal
Atrial Fibrillation Shows Prolonged Atrial
Conduction Time by Signal-Averaged P-Wave
Electrocardiogram
The relationship between the cortisol response to corticotropin and vessels
a-adrenoreceptor sensitivity to dopamine is assessed in 20 patients fulfill-
ing Bone's criteria for septic shock, by drawing dose-response curves for
mean arterial pressure (MAP. mmHg, beat-to-beat recording of finger blood
pressure, Finapress) during stepwise incremental doses of dopamine ID,
/Lgikg/min, 0-2.5-5-7.5-10-12.5-15- 20-25-30). Just before 0 administra-
tion all patients undergo a short corticotropin stimulation test (Synacthen,
Ciba) consisting of a 0.25 mg IV bolus of tetracosactrin Iplasma cortisol lev-
els, nglml, are assessed immediately before the test and 30 and 60 minutes
afterwards). The cortisol response to corticotropin is defined as the greater
difference between baseline and 30 and 60 minutes plasma cortisol levels
(Dm.xCort, ng/ml). Dose response curve fitting parameters are estimated in
individual subjects using a multiple dose non linear regression program (SY-
STAT, Inc software). The relationship between curve fitting parameters and
0maxCort is studied by using the Spearman correlation test. The mean val-
ues of curve fitting parameters are Emax = 81 ± 23 (mmHg) and EC50 = 6.3
± 2.5 (0 titration giving 50% of Emax, /Lg/kg/min). Basal cortisol concentra-
tions and Om.x Cort are respectively 439 ± 284 and 111 ± 192 (ng/ml). Emax
correlated positively and strongly with Dmax Cort Ip = 0.007). No relation-
ship is found between Om.xCort and EC50, plasma norepinephrine levels,
and arterial lactates. We conclude that the weaker the cortisol response to
corticotropin the more hypereactive the vessels in human septic shock. This
result underlines the key role of endogenous steroids in vascular tone regu-
lation during sepsis, and raises again the usefulness of physiological doses
of steroids rather than high doses for the management of septic shock.
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The purpose of this study was to establish a relationship between the atrial
activation assessed by signal-averaged P wave ECG (SAPW! and episodes
of paroxysmal atrial fibrillation (PAF! in patients (pts) with WPW syndrome
IWPWS). Methods: fourteen pts with documented episodes of PAF, without
underlying heart disease were selected (12 men: age = 35.2 ± 11.1 years)
from a total of 70 consecutives pts successfully submitted to radiofrequency
catheter ablation of accessory pathway (AP!. All pts with anterograde con-
duction over the AP. left side AP in 9 pts and right side AP in 5 pts. The
SAPW were recorded with the Corazonix Predictor II system from the X, Y,
Z leads (40-250 Hz, least Square filter, final noise < 0.3 /LV). The total filter
P wave duration (PWO) was obtained manually from the vector-magnitude
in ms. Recordings were performed between 7th and 14th day after the ab-
lation. No pts showed left atrial larger than 4.0 cm on the echocardiogram.
The results were compared with a control group of 12 pts matched in age (5
men; age = 33.0 ± 10.2 years) without heart disease. Values were given as
mean and 1 SO and compared using non-paired Student t test (significance <
0.05). Results: Control Group In = 12): PWO ranged from 115.0 to 129.5 ms
with a mean of 124.4 ± 4.4 ms. WPWS with PAF (n = 14): PWO ranged from
130.0 to 171.0 ms with a mean of 142.9 ±1 0.1 ms (p < 0.000). Eleven pts
(78.5%) showed PWO > 135.0 ms. There were no differences between PWD
and AP location. Recurrent PAF after ablation was noted in 3 pts (21 % -
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defibrillation achieved with a single lead right ventricular coil/defibrillator can
system.
PWO: 171.0, 1505 and 139.0 ms for each patient). With a cutoff <135.0 ms
for a normal PWO, the sensitivity was 78.5%, the specificity was 100%; the
positive predictive value was 100% and the negative was 75% for SAPW
to identify pts with WPWS and PAF. Conclusions: In the current study, pts
with WPWS and PAF showed prolonged intra-atrial conduction time when
compared with a control group. This may contribute to the development of
PAF.
11026-85\ Enhanced Defibrillation Efficacy with an Active
Pectoral Pulse Generator
RV/CAN 90mm2 160 mm2 617 mm2
OFT(J) 8.6 ± 3.3 8.1 ± 2.6 8.2 ± 2.5 4.9 ± 1.9*
Voltage (V) 373 ± 73 365 ± 58 367 ± 65 284 ± 53*
Impedance 74 ± 24 53 ± 13+ 48 ± 11+ 52 ± 10+
Conclusion: We found a poor correlation between the biphasic ULV and
the OFT using this clinically feasible followup technique. The ULV appears to
underestimate the OFT using this technique for evaluating ICO defibrillation
















The Influence of Sodium Channel Blockade on
the Defibrillation Threshold of Biphasic versus
Monophasic Defibrillation Waveforms
Long-term Changes in Defibrillation Thresholds












*p value of monophasic vs biphasic. **p value of baseline vs LIDO
In 2 dogs, the OFT during LIDO was >50 joules with monophasic shock
and 27.9 ± 5.6 joules with biphasic shocks. LIDO caused a 13.1 ± 9.8%
increase in ventricular refractoriness (p < 0.037) and a 29.8 ± 22.7% increase
in GAS duration (p < 0.01). neither of which were predictive of OFT response.
Conclusion: Sodium channel blockade does increase the OFT of biphasic
shocks but to a lesser extent than observed with monophasic shock OFT's.
These results may have favorable implications for the use of Class I antiar-
rhythmics in patients with newer generation lCD's.
An active pectoral pulse generator can be incorporated in a single coil defib-
rillation lead system to achieve low defibrillation thresholds (OFT). However,
the incremental benefit of an active pulse generator with an integrated lead
system has not been evaluated. Accordingly, we performed a prospective
trial of a 65 cc pulse generator shell with an Endotak lead in 22 consecutive
pts undergoing defibrillator implantation. Energy (E) and leading edge volt-
age (V) at OFT was measured using a step down protocol to first failure with
biphasic waveforms (60:40 tilt). Either lead alone (proximal coil = anode) or
lead + shell (proximal coil and shell = anode) were tested with paired testing
in random order.
Michael B. Lenhart, Amir Saffarin, Steven O. Nelson. The Ohio State University,
Columbus, OH
Several Class I antiarrhythmic drugs are known to increase the defibrillation
threshold 10FT) of monophasic shock waveforms delivered by implantable
defibrillators (ICD). The influence of sodium channel blockade on biphasic
shocks is unknown. The purpose of this study was to determine the effects
of lidocaine (LIDO) on the OFT with biphasic versus monophasic shock wave-
forms in an anesthetized canine model of transvenous defibrillation In =
101. The OFT was determined by the iterative increment-decrement proto-
col. Monophasic and biphasic shock OFT's were tested in random order at
baseline and during LIDO infusion (8 mg/kg load; 400 microgmlkg/min) and
presented below.
A DFT of :s10J was found in 50% (11/22) of patients with lead alone and
86% (19/22) of patients with lead + shell (p < 0.02).
In conclusion, adding an active pulse generator to an integrated transve-
nous lead significantly reduced OFTs and system impedance IRl. The consis-
tently low defibrillation energy requirements with the use of an active small
pectoral shell, makes the development of a defibrillator with reduced size
and lower maximal output feasible.
Andrea Russo, Lou-Anne Beauregard, Catherme Stubin, Harvey L. Waxman.
Cooper Hospital, UMDNJIRobert Wood Johnson Medical School, Camden, NJ
We implanted nonthoracotomy defibrillators in consecutive pts with sus-
tained ventricular arrhythmias. A Ventritex Cadence (V-l00C) device using
a bipbasic waveform was implanted in all pts. The first 21 systems (Grp I)
consisted of a CPI (BT-1 0) endocardial lead at the AV apex for sensing and
pacing, with a CPIIC-l 0) spring electrode at the SVC/HAAjunction and a large
CPI patch (L67) implanted subcutaneously in the left axillary region for de-
fibrillation. A single lead defibrillation system (CPI Endotak C, Model #0064)
was implanted in 27 pts (Grp II). Mean age was 61 ± 12 years and LVEF
was 37 ± 16%, Three successful shocks for sustained VF were required to
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Impact of the Defibrillating Surface Area of an
Additional Superior Vena Cava Electrode on the
Unipolar Right Ventricular Coil/Defibrillator Can
System
ULV OFT
6.B ± 44 102 ± 5.5
r = 0.49, p ~ 0.11
Prospective Comparison of the Biphasic
Waveform Upper Limit of Vulnerability to the
Defibrillation Threshold in Man
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Background: The upper limit of vulnerability (ULV) is defined as the upper
limit of shock strength, above which ventricular fibrillation will not be induced
when the shock is delivered during the vulnerable period. ULV is postulated
to correlate with the defibrillation threshold (DFT) and, if true, should stream-
line implantable cardioverter-defibrillator (ICD) surgery and followup.
Methods and Results: We sought to determine whether the biphasic
ULV, measured with an easily implemented clinical protocol via the T-shock
method available in the 72190 Medtronic ICO using 65% tilt, 120 J.LF asym-
metric pulses, would correlate with the biphasic OFT assessed during follow
up electrophysiologic IEP) evaluation of ICD function. Twelve consecutive
patients were evaluated. The average age was 67 ± 3.4 years, LV ejection
fraction was 0.45 ± 0.04, and 58% had underlying CAD. The index arrhyth-
mia prompting ICO therapy was VF in 83% and VT in 17%. At the time of
the follow-up EP study, all patients had VF induced with T-shocks at 31 0 ms
following 3 ventricular paced beats at 400 ms starting at 0.2 Joules and step-
ping up until the ULVwas found as follows: 0.6, 1.0, 2.0, 3.0, 40, 5.0, 7.0,10,
14, and 18 Joules. The OFT was determined using the exact same waveform,
polarity and shock steps as was the ULV determination.
Results:
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We assessed the hypothesis that the surface area of an additional superior
vena cava (SVCI defibrillation electrode may impact on the defibrillation ef-
ficacy of a right ventricular (RV) coil/CAN system. In ten dogs we randomly
compared the energy requirements for defibrillation (OFT) using the AV/CAN
configuration and three triple lead systems employing an additional lead in
the SVC with a defibrillating surface area of 90 mm2, 160 mm2 and 617 mm2
respectively. Biphasic shocks with 65% fixed tilt were used for defibrillation.
Triplicate defibrillation thresholds were determined with each lead system.
With every electrode system the AV coil was used as cathode. Energy (J).
peak voltage (VI and impedance at defibrillation threshold are shown below:
*617 mm2 vs RV/CAN p < 0.01
+90 mm2 160 mm2, 617 mm2 vs RV/CAN p < 0.01
These results indicate that the surface area of an additional SVC defib-
rillating electrode may be critical to improving the energy requirement for
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